SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for DNTH.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical SG&A Expense (TTM) Data

View and export this data back to 2017. Start Trial.
Date Value
June 30, 2026 44.15M
March 31, 2026 39.46M
December 31, 2025 34.33M
September 30, 2025 31.23M
June 30, 2025 29.56M
March 31, 2025 26.69M
December 31, 2024 24.99M
September 30, 2024 22.80M
June 30, 2024 24.99M
March 31, 2024 21.49M
December 31, 2023 18.16M
September 30, 2023 15.56M
June 30, 2023 9.05M
March 31, 2023 13.04M
December 31, 2022 18.01M
September 30, 2022 23.00M
June 30, 2022 28.24M
March 31, 2022 28.24M
December 31, 2021 27.93M
Date Value
September 30, 2021 27.71M
June 30, 2021 26.85M
March 31, 2021 27.78M
December 31, 2020 28.09M
September 30, 2020 27.20M
June 30, 2020 26.73M
March 31, 2020 25.23M
December 31, 2019 23.76M
September 30, 2019 23.38M
June 30, 2019 22.54M
March 31, 2019 20.98M
December 31, 2018 18.62M
September 30, 2018 13.08M
June 30, 2018 9.604M
March 31, 2018 7.177M
December 31, 2017 5.209M
September 30, 2017 5.209M
June 30, 2017 3.404M
March 31, 2017 1.489M

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Legend Biotech Corp. 376.01M
Ironwood Pharmaceuticals, Inc. 64.55M
Verastem, Inc. 95.16M
Fortress Biotech, Inc. 68.84M
AbbVie, Inc. 14.67B